These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28603208)

  • 1. Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.
    Okazawa H
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(6):361-377. PubMed ID: 28603208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?
    Venkataraman A; Kalk N; Sewell G; W Ritchie C; Lingford-Hughes A
    Alcohol Alcohol; 2017 Mar; 52(2):158. PubMed ID: 28182204
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular amyloid hypothesis for ultra-early phase pathology of Alzheimer's disease.
    Okazawa H
    Neuropathology; 2021 Apr; 41(2):93-98. PubMed ID: 33876503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease.
    Korsak M; Kozyreva T
    Adv Exp Med Biol; 2015; 870():401-21. PubMed ID: 26387111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic approaches unraveling regulation and aggregation of intrinsically disordered β-amyloids implicated in Alzheimer's disease.
    Kumari A; Rajput R; Shrivastava N; Somvanshi P; Grover A
    Int J Biochem Cell Biol; 2018 Jun; 99():19-27. PubMed ID: 29571707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
    Kanemaru K
    Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Alzheimer to Huntington: why is a structural understanding so difficult?
    Temussi PA; Masino L; Pastore A
    EMBO J; 2003 Feb; 22(3):355-61. PubMed ID: 12554637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of metal ions in the abeta oligomerization in Alzheimer's disease and in other neurological disorders.
    Drago D; Bolognin S; Zatta P
    Curr Alzheimer Res; 2008 Dec; 5(6):500-7. PubMed ID: 19075576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta, tau protein, and oxidative changes as a physiological compensatory mechanism to maintain CNS plasticity under Alzheimer's disease and other neurodegenerative conditions.
    Koudinov A; Kezlya E; Koudinova N; Berezov T
    J Alzheimers Dis; 2009; 18(2):381-400. PubMed ID: 19749430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of machine learning models to detect amyloid pathologies across institutions.
    Vizcarra JC; Gearing M; Keiser MJ; Glass JD; Dugger BN; Gutman DA
    Acta Neuropathol Commun; 2020 Apr; 8(1):59. PubMed ID: 32345363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ42 and Aβ40: similarities and differences.
    Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
    J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.